falseIngevity Corp000165347700016534772020-06-022020-06-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________________________ 
FORM 8-K
_______________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

June 2, 2020
Date of Report (date of earliest event reported)
__________________________________________________________________________
NGVT-20200602_G1.JPG
INGEVITY CORPORATION
(Exact name of registrant as specified in its charter)
__________________________________________________________________________ 
Delaware 001-37586 47-4027764
(State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.)
5255 Virginia Avenue North Charleston South Carolina 29406
(Address of principal executive offices) (Zip code)


Registrant’s telephone number, including area code: 843-740-2300

Not Applicable
(Former name or former address, if changed since last report)
_____________________________________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock ($0.01 par value) NGVT New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act o
_____________________________________________________________________________________________________


ITEM 8.01. OTHER EVENTS

On June 2, 2020, Ingevity Corporation (the “Company”) issued a press release describing certain cost reduction initiatives designed to support its ability to meet its revised guidance range it set forth in its first quarter 2020 earnings release. The Company stated on April 29, 2020 that it expects fiscal year 2020 sales of between $1.10 billion and $1.20 billion and adjusted EBITDA of between $310 million and $350 million. Rick Kelson, chairman of the board, and interim president and CEO also announced that the Company expects more significant impacts from the coronavirus to begin in the second quarter.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.
Exhibit No. Description of Exhibit
Press release dated June 2, 2020.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INGEVITY CORPORATION
(Registrant)
By: /S/ JOHN C. FORTSON
John C. Fortson
Executive Vice President, Chief Financial Officer, and Treasurer
Date: June 2, 2020


Ingevity (NYSE:NGVT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ingevity Charts.
Ingevity (NYSE:NGVT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ingevity Charts.